Back to Search
SUSAN O'MALLEY, M.D.
M.D.
Internal Medicine Physician
NPI: 1336586502Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
035328(CT)
Research & Publications (20)
Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.
PMID 18796184·Int J Neuropsychopharmacol·2009
4-observational
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
PMID 18482155·Alcohol Clin Exp Res·2008
2-rct
Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
PMID 17873686·J Clin Psychopharmacol·2007
2-rct
Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
PMID 17374042·Alcohol Clin Exp Res·2007
2-rct
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
PMID 16567607·Arch Intern Med·2006
2-rct
How pilot studies improve large-scale clinical trials: lessons learned from the COMBINE Study.
PMID 16223058·J Stud Alcohol Suppl·2005
8-other
Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
PMID 12885685·Arch Intern Med·2003
3-trial
Advances in the use of naltrexone: an integration of preclinical and clinical findings.
PMID 12638640·Recent Dev Alcohol·2003
4-observational
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
PMID 11862370·Psychopharmacology (Berl)·2002
3-trial
Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects.
PMID 10653211·J Clin Psychopharmacol·2000
8-other
Cranberry and grape seed extracts inhibit the proliferative phenotype of oral squamous cell carcinomas.
PMID 18955355·Evid Based Complement Alternat Med·2011
8-other
Priorities for improving the scientific foundation of conservation policy in North America.
PMID 19627314·Conserv Biol·2009
8-other
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.
PMID 19487632·Arch Gen Psychiatry·2009
8-other
Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.
PMID 19633277·Nicotine Tob Res·2009
8-other
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking.
PMID 19440191·Neuropsychopharmacology·2009
8-other
Depressive symptoms, drinking consequences, and motivation to change in first time DWI offenders.
PMID 19462293·Am J Drug Alcohol Abuse·2009
8-other
A successful practical application of Coverage with Evidence Development in Australia: Medical Services Advisory Committee interim funding and the PillCam Capsule Endoscopy Register.
PMID 19619347·Int J Technol Assess Health Care·2009
8-other
Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.
PMID 19586156·Psychol Addict Behav·2009
8-other
Horizon scanning of new and emerging medical technology in Australia: its relevance to Medical Services Advisory Committee health technology assessments and public funding.
PMID 19619357·Int J Technol Assess Health Care·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 869 BOSTON POST RD
MADISON, CT 06443 - Phone
- (203) 520-3227
Quick Facts
- NPI
- 1336586502
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile